Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies
Clinical trial NCT00381654 · TERMINATED
Trial details
- NCT number
- NCT00381654
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2009-12-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.